Flinton Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-11,376
| Closed | -$71K | – | 922 |
|
|
2018
Q3 | $71K | Buy |
11,376
+816
| +8% | +$5.09K | ﹤0.01% | 816 |
|
|
2018
Q2 | $85K | Hold |
10,560
| – | – | ﹤0.01% | 785 |
|
|
2018
Q1 | $79K | Buy |
10,560
+2,480
| +31% | +$18.6K | ﹤0.01% | 787 |
|
|
2017
Q4 | $48K | Buy |
8,080
+2,048
| +34% | +$12.2K | ﹤0.01% | 815 |
|
|
2017
Q3 | $44K | Buy |
6,032
+1,456
| +32% | +$10.6K | ﹤0.01% | 814 |
|
|
2017
Q2 | $31K | Buy |
4,576
+2,448
| +115% | +$16.6K | ﹤0.01% | 822 |
|
|
2017
Q1 | $20K | Buy |
+2,128
| New | +$20K | ﹤0.01% | 826 |
|